Antimicrobial Activity and Spectrum Investigation of Eight Broad-Spectrum β-Lactam Drugs: A 1997 Surveillance Trial in 102 Medical Centers in the United States
- 31 March 1998
- journal article
- research article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 30 (3), 215-228
- https://doi.org/10.1016/s0732-8893(97)00234-4
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Is it important to identify extended-spectrum beta-lactamase-producing isolates?European Journal of Clinical Microbiology & Infectious Diseases, 1996
- In-vitro susceptibility of Klebsiella oxytoca strains to 13 β-lactams in the presence and absence of β-lactamase inhibitorsJournal of Antimicrobial Chemotherapy, 1996
- Ceftazidime Resistance Among Selected Nosocomial Gram-Negative Bacilli In The United StatesThe Journal of Infectious Diseases, 1994
- Antimicrobial activity of FK-037, a new broad-spectrum cephalosporin international in vitro comparison with cefepime and ceftazidimeDiagnostic Microbiology and Infectious Disease, 1994
- CefepimeDrugs, 1994
- Development of resistance in Pseudomonas aeruginosa to broad-spectrum cephalosporins via step-wise mutationsJournal of Antimicrobial Chemotherapy, 1993
- A non-comparative study of the efficacy and tolerance of cefepime in combination with amikacin in the treatment of severe infections in patients in intensive careJournal of Antimicrobial Chemotherapy, 1993
- Evaluation of the E test, a novel method of quantifying antimicrobial activityJournal of Antimicrobial Chemotherapy, 1991
- Activity of cefepime against ceftazidime- and cefotaxime-resistant gram-negative bacteria and its relationship to beta-lactamase levelsAntimicrobial Agents and Chemotherapy, 1989
- In vitro activity of carumonam (RO 17-2301), BMY-28142, aztreonam, and ceftazidime against 7620 consecutive clinical bacterial isolatesDiagnostic Microbiology and Infectious Disease, 1986